Primary |
Type 1 Diabetes Mellitus |
27.2% |
Type 2 Diabetes Mellitus |
21.3% |
Insulin-requiring Type Ii Diabetes Mellitus |
9.5% |
Diabetes Mellitus |
8.5% |
Hypertension |
6.6% |
Diabetes Mellitus Insulin-dependent |
4.4% |
Drug Use For Unknown Indication |
4.2% |
Asthma |
2.4% |
Gastric Ulcer |
1.8% |
Pustular Psoriasis |
1.8% |
Hyperuricaemia |
1.6% |
Atrial Fibrillation |
1.2% |
Dermatomyositis |
1.2% |
Diabetic Retinopathy |
1.2% |
Gastritis |
1.2% |
Insulin-requiring Type 2 Diabetes Mellitus |
1.2% |
Product Used For Unknown Indication |
1.2% |
Renal Failure Chronic |
1.2% |
Rheumatoid Arthritis |
1.2% |
Angina Pectoris |
1.0% |
|
Suicide Attempt |
17.7% |
Hypoglycaemia |
15.3% |
Hepatic Function Abnormal |
9.7% |
Hypoglycaemic Coma |
4.8% |
Intentional Overdose |
4.8% |
Oedema Peripheral |
4.8% |
Blood Glucose Fluctuation |
4.0% |
Hypoglycaemic Encephalopathy |
4.0% |
Liver Disorder |
4.0% |
Anti-insulin Antibody Positive |
3.2% |
Interstitial Lung Disease |
3.2% |
Threatened Labour |
3.2% |
Weight Increased |
3.2% |
Wrong Drug Administered |
3.2% |
Feeling Abnormal |
2.4% |
Hyperglycaemia |
2.4% |
Hypoglycaemic Unconsciousness |
2.4% |
Pregnancy |
2.4% |
Rash |
2.4% |
Retinal Haemorrhage |
2.4% |
|
Secondary |
Type 2 Diabetes Mellitus |
38.3% |
Diabetes Mellitus |
9.9% |
Type 1 Diabetes Mellitus |
8.4% |
Insulin-requiring Type Ii Diabetes Mellitus |
8.0% |
Product Used For Unknown Indication |
6.9% |
Drug Use For Unknown Indication |
5.9% |
Hypertension |
5.9% |
Diabetes Mellitus Insulin-dependent |
3.2% |
Insulin-requiring Type 2 Diabetes Mellitus |
3.2% |
Dyslipidaemia |
1.5% |
Hyperlipidaemia |
1.1% |
Rheumatoid Arthritis |
1.1% |
Benign Prostatic Hyperplasia |
0.9% |
Cerebral Infarction |
0.9% |
Herpes Zoster |
0.9% |
Diabetic Neuropathy |
0.8% |
Myocardial Infarction |
0.8% |
Tension Headache |
0.8% |
Constipation |
0.7% |
Diabetic Ketoacidosis |
0.6% |
|
Hypoglycaemia |
25.9% |
Diabetes Mellitus Inadequate Control |
8.9% |
Suicide Attempt |
7.0% |
Anti-insulin Antibody Positive |
5.7% |
Hyperglycaemia |
5.7% |
Blood Glucose Fluctuation |
5.1% |
Weight Increased |
5.1% |
Drug Hypersensitivity |
4.4% |
Hypoglycaemic Coma |
4.4% |
Rash |
4.4% |
Vomiting |
3.8% |
Diabetic Ketoacidosis |
2.5% |
Hypoglycaemic Encephalopathy |
2.5% |
Hypoglycaemic Unconsciousness |
2.5% |
Liver Disorder |
2.5% |
Hepatic Function Abnormal |
1.9% |
Injection Site Swelling |
1.9% |
Insulin Autoimmune Syndrome |
1.9% |
Interstitial Lung Disease |
1.9% |
Oedema Peripheral |
1.9% |
|
Concomitant |
Type 2 Diabetes Mellitus |
22.3% |
Type 1 Diabetes Mellitus |
14.4% |
Spinal Osteoarthritis |
11.5% |
Insomnia |
7.2% |
Gastric Ulcer |
5.8% |
Insulin-requiring Type 2 Diabetes Mellitus |
5.8% |
Hypertension |
5.0% |
Constipation |
3.6% |
Headache |
3.6% |
Nausea |
3.6% |
Pyrexia |
3.6% |
Diabetes Mellitus |
2.9% |
Diabetes Mellitus Insulin-dependent |
2.2% |
Diabetic Nephropathy |
2.2% |
Latent Autoimmune Diabetes In Adults |
2.2% |
Psoriasis |
1.4% |
Autonomic Neuropathy |
0.7% |
Drug Use For Unknown Indication |
0.7% |
Dyslipidaemia |
0.7% |
Hypothyroidism |
0.7% |
|
Sensory Disturbance |
13.3% |
Hepatic Function Abnormal |
6.7% |
Hepatitis A |
6.7% |
Hypoglycaemia |
6.7% |
Intestinal Obstruction |
6.7% |
Muscle Spasms |
6.7% |
Rash |
6.7% |
Type Iv Hypersensitivity Reaction |
6.7% |
Urticaria |
6.7% |
Anti-insulin Antibody Positive |
3.3% |
Hypoglycaemic Unconsciousness |
3.3% |
Ileus Paralytic |
3.3% |
Latent Autoimmune Diabetes In Adults |
3.3% |
Liver Disorder |
3.3% |
Oxygen Saturation Decreased |
3.3% |
Pancreatitis Acute |
3.3% |
Pruritus |
3.3% |
Renal Disorder |
3.3% |
Sudden Death |
3.3% |
|